BAROSI G; BOCCADORO M; CAVO M.; CORRADINI P; MARCHETTI M; MASSAIA M; MERLINI G; TOSI P; TURA S; ITALIAN SOCIETY OF HEMATOLOGY; ITALIAN SOCIETY OF EXPERIMENTAL HEMATOLOGY; ITALIAN GROUP FOR BONE MARROW TRANSPLANTATION., Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO)., «HAEMATOLOGICA», 2004, 89, pp. 717 - 741 [articolo]
M. Cavo, New insights into the knowledge of graft-versus-myeloma, «BLOOD», 2004, 103, pp. 371 - 372 [replica/breve intervento]
TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M., Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2004, 73, pp. 98 - 103 [articolo]
Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A., Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma, in: , «QUARTERLY JOURNAL OF NUCLEAR MEDICINE», 2004, 46, pp. 89 - 89 (atti di: Congresso Italiano AIMN, Palermo, 2004) [atti di convegno-abstract]
Baccarani M.; Gobbi M.; Cavo M.; Tura S., Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl), «HAEMATOLOGICA», 1979, 64, pp. 98 - 104 [articolo]
